AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EMV CAPITAL PLC

Regulatory News Service Nov 20, 2025

7623_rns_2025-11-20_82021500-af76-440b-82a3-a355c3bddf0a.html

Regulatory News Service

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2656I

EMV Capital PLC

20 November 2025

For announcement on Reach: 07:00, 20 November 2025

EMV Capital plc

("EMVC" or the "Company")

Portfolio Update

As part of its ongoing investor engagement programme, EMV Capital plc (AIM: EMVC), the deep tech and life sciences VC investment group, is pleased to announce that it will host a virtual Meet the Portfolio event on 1 December 2025 at 2.00 p.m. The session will provide investors with greater insight into two of its portfolio companies, Wanda Health and Deeptech Recycling.

Virtual Meet the Portfolio - Wanda Health and DeepTech Recycling

The online event will take place via the Investor Meet Company platform and will be hosted by Dr. Ilian Iliev, CEO of EMV Capital plc, who will be joined by the CEOs of:

·     Wanda Health, the intelligent platform for Remote Patient Monitoring and Virtual Care; and

·   DeepTech Recycling, the advanced technology platform transforming unrecyclable plastics into sustainable resources.

This presentation is open to all interested parties. Anyone can sign up for free and join the live presentation via:

https://www.investormeetcompany.com/emv-capital-plc/register-investor

Those who already follow the Company on the Investor Meet Company platform will automatically be invited. 

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 30 November 2025, 09:00 a.m., or at any time during the live presentation.

In accordance with UK Market Abuse Regulation (UK MAR), no inside information will be disclosed during the event.

-Ends- 

For more information, please contact:

EMV Capital plc via Rosewood
Ilian Iliev, CEO
Panmure Liberum Limited (NOMAD and Broker) +44 (0)20 7886 2500
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)
Rupert Dearden (Corporate Broking)
Rosewood (Financial PR) +44 (0)20 7653 8702
John West / Llewellyn Angus / Lily Pearce

About EMV Capital plc (EMVC)

EMV Capital plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early-stage IP-rich companies.

EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:

·     capital-efficient investments through Group balance sheet;

·     fund management of the Evergreen EIS and Martlet Capital Funds;

·     syndicated investments leveraging its network of third-party investors.

EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.

Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.

www.emvcapital.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAUKUARVVUAAUA

Talk to a Data Expert

Have a question? We'll get back to you promptly.